Clinical trials
Observational Gastroenteritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 12 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 12 |
| MeMed Diagnostics Ltd. | 2 |
| AbbVie | 1 |
| American University of Beirut Medical Center | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Associate Professor Helen Marshall | 1 |
| Association Clinique Thérapeutique Infantile du val de Marne | 1 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroenteritis | 51 |
| Rotavirus Infections | 9 |
| Dehydration | 4 |
| Diarrhea | 4 |
| Communicable Diseases | 3 |
| Gastrointestinal Diseases | 3 |
| Respiratory Tract Infections | 3 |
| Appendicitis | 2 |
| Bronchiolitis | 2 |
| COVID-19 | 2 |
Trials
Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.